>
  1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Regents Of The University Of California Buys Alibaba Group Holding, Allogene Therapeutics Inc, Revolution Medicines Inc, Sells BTC iShares iBoxx USD High Yield Corporate Bond ET, Constellation Pharmaceuticals Inc, Bloom Energy Corp

Oakland, CA, based Investment company Regents Of The University Of California (Current Portfolio) buys Alibaba Group Holding, Allogene Therapeutics Inc, Revolution Medicines Inc, Inari Medical Inc, sells BTC iShares iBoxx USD High Yield Corporate Bond ET, Constellation Pharmaceuticals Inc, Bloom Energy Corp, Global Blood Therapeutics Inc, Arvinas Inc during the 3-months ended 2020Q4, according to the most recent filings of the investment company, Regents Of The University Of California. As of 2020Q4, Regents Of The University Of California owns 28 stocks with a total value of $692 million. These are the details of the buys and sells.

For the details of REGENTS OF THE UNIVERSITY OF CALIFORNIA's stock buys and sells, go to https://www.gurufocus.com/guru/regents+of+the+university+of+california/current-portfolio/portfolio

These are the top 5 holdings of REGENTS OF THE UNIVERSITY OF CALIFORNIA
  1. Owl Rock Capital Corp (ORCC) - 42,690,843 shares, 78.07% of the total portfolio.
  2. Alibaba Group Holding Ltd (BABA) - 177,072 shares, 5.95% of the total portfolio. New Position
  3. Allogene Therapeutics Inc (ALLO) - 900,143 shares, 3.28% of the total portfolio. New Position
  4. RAPT Therapeutics Inc (RAPT) - 1,122,237 shares, 3.20% of the total portfolio. Shares reduced by 18.72%
  5. Constellation Pharmaceuticals Inc (CNST) - 737,406 shares, 3.07% of the total portfolio. Shares reduced by 40.41%
New Purchase: Alibaba Group Holding Ltd (BABA)

Regents Of The University Of California initiated holding in Alibaba Group Holding Ltd. The purchase prices were between $222 and $317.14, with an estimated average price of $276.59. The stock is now traded at around $260.000000. The impact to a portfolio due to this purchase was 5.95%. The holding were 177,072 shares as of 2020-12-31.

New Purchase: Allogene Therapeutics Inc (ALLO)

Regents Of The University Of California initiated holding in Allogene Therapeutics Inc. The purchase prices were between $25.24 and $43.45, with an estimated average price of $32.42. The stock is now traded at around $31.340000. The impact to a portfolio due to this purchase was 3.28%. The holding were 900,143 shares as of 2020-12-31.

New Purchase: Revolution Medicines Inc (RVMD)

Regents Of The University Of California initiated holding in Revolution Medicines Inc. The purchase prices were between $30.19 and $45.49, with an estimated average price of $39.69. The stock is now traded at around $43.250000. The impact to a portfolio due to this purchase was 0.8%. The holding were 140,155 shares as of 2020-12-31.

New Purchase: Inari Medical Inc (NARI)

Regents Of The University Of California initiated holding in Inari Medical Inc. The purchase prices were between $60 and $87.29, with an estimated average price of $70.82. The stock is now traded at around $105.540000. The impact to a portfolio due to this purchase was 0.05%. The holding were 4,152 shares as of 2020-12-31.

Sold Out: BTC iShares iBoxx USD High Yield Corporate Bond ET (HYG)

Regents Of The University Of California sold out a holding in BTC iShares iBoxx USD High Yield Corporate Bond ET. The sale prices were between $82.43 and $87.3, with an estimated average price of $85.02.

Sold Out: Bloom Energy Corp (BE)

Regents Of The University Of California sold out a holding in Bloom Energy Corp. The sale prices were between $12.64 and $30.59, with an estimated average price of $21.64.

Sold Out: Global Blood Therapeutics Inc (GBT)

Regents Of The University Of California sold out a holding in Global Blood Therapeutics Inc. The sale prices were between $37.65 and $63.77, with an estimated average price of $49.03.

Sold Out: Arvinas Inc (ARVN)

Regents Of The University Of California sold out a holding in Arvinas Inc. The sale prices were between $20.19 and $84.93, with an estimated average price of $35.2.

Sold Out: FinVolution Group (FINV)

Regents Of The University Of California sold out a holding in FinVolution Group. The sale prices were between $1.85 and $2.67, with an estimated average price of $2.14.



Here is the complete portfolio of REGENTS OF THE UNIVERSITY OF CALIFORNIA. Also check out:

1. REGENTS OF THE UNIVERSITY OF CALIFORNIA's Undervalued Stocks
2. REGENTS OF THE UNIVERSITY OF CALIFORNIA's Top Growth Companies, and
3. REGENTS OF THE UNIVERSITY OF CALIFORNIA's High Yield stocks
4. Stocks that REGENTS OF THE UNIVERSITY OF CALIFORNIA keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:



Performances of the stocks mentioned by insider


User Generated Screeners


pjmason14Momentum
wigbertHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)